Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist Prescriptions

MONDAY, July 22, 2024 -- From 2011 to 2023, there was an increase in new glucagon like peptide 1 receptor agonist (GLP-1RA) prescriptions, according to a...

Study Looks at Co-Use of CYP2D6-Metabolizing Opioids, Antidepressants in Seniors

MONDAY, July 22, 2024 -- For older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with CYP2D6-inhibiting antidepressants is...

Variety of Digital Apps Aid Mental Health Symptoms in Adults

MONDAY, July 22, 2024 -- Mindfulness-based, cognitive behavioral therapy (CBT)-based, and personalized feedback digital interventions are similarly effective...

Healthy Prenatal Dietary Pattern Tied to Lower Odds of Autism in Offspring

MONDAY, July 22, 2024 -- High adherence to a healthy prenatal dietary pattern is associated with reduced odds of autism diagnosis in offspring, according to a...

Medical Debt Common in Adults With Depression, Anxiety

MONDAY, July 22, 2024 -- Medical debt is common among adults with depression and anxiety and may contribute to the mental health treatment gap, according to a...

FDA Approves Epysqli (eculizumab-aagh), a Biosimilar to Soliris

INCHEON, South Korea, July 22, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved...

Two More Bird Flu Cases Reported in Colorado Poultry Workers

MONDAY, July 22, 2024 -- Two more cases of bird flu have been reported in Colorado poultry workers, but reassuring research finds the virus doesn't seem to be...

CDC Warns of Listeria Outbreak Tied to Deli Meats

MONDAY, July 22, 2024 -- At least 28 people have been hospitalized and two have died in a multi-state outbreak of listeria linked to deli meat, U.S. health...

Scientists May Have Stopped a Form of Inherited Blindness in Dogs

MONDAY, July 22, 2024 -- In her youth, Shola, an English Shepherd Dog, was a member of the Edale Mountain Rescue Team, a corps of U.K. pooches charged with...

Dogs Can Smell Your Stress and Make Choices Based on It

MONDAY, July 22, 2024 -- Dogs can sniff out whether a human is stressed or relaxed, new research suggests, and that sensory feedback appears to influence...

Daily Supplements May Slow 'Dry' Form of Macular Degeneration

MONDAY, July 22, 2024 -- Daily supplements can slow loss of vision related to late-stage “dry” age-related macular degeneration (AMD), a new study...

Phathom Pharmaceuticals Announces FDA Approval of Voquezna (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults

FLORHAM PARK, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and...

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

THOUSAND OAKS, Calif.--(BUSINESS WIRE) July 17, 2024 -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel...

Orexo Receives a Complete Response Letter Regarding the NDA for OX124, a High-Dose Naloxone Rescue Medication in Development for Opioid Overdose

Uppsala, Sweden – July 16, 2024 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces that the company has received a complete response...

Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission

The Woodlands, Texas, July 16, 2024 - Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that the U.S. Food and Drug Administration (FDA) has...

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

DEER PARK, Ill., July 15, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative...

FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company...

FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss

South San Francisco, CA -- July 4, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. Food and Drug...

FDA Approves Kisunla (donanemab-azbt) for the Treatment of Early Symptomatic Alzheimer's Disease

INDIANAPOLIS, July 2, 2024 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly...

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis

BOSTON--(BUSINESS WIRE)--Jul. 2, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has...

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia

EDINBURGH, Scotland, July 22, 2024. TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company"), a clinical stage biotechnology company developing platform...

Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease

CARLSBAD, Calif., July 18, 2024. Ionis Pharmaceuticals, Inc. announced today that it has completed enrollment in the pivotal trial of zilganersen (ION373), an...

Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for Botensilimab/Balstilimab (BOT/BAL) in MSS Colorectal Cancer

LEXINGTON, Mass.--(BUSINESS WIRE) July 18, 2024 -- Agenus Inc. (NASDAQ: AGEN), a leader in developing novel immunological agents to treat various cancers...

FDA Clears Investigational New Drug application for muscular dystrophy treatment

MINNEAPOLIS and ST. PAUL, Minn., July 17, 2024. Today, Myogenica, a University of Minnesota startup company, announced U.S. Food and Drug Administration...

Evommune Announces Positive Proof-of-Concept Clinical Trial Results for its MRGPRX2 Antagonist

PALO ALTO, Calf., July 16, 2024. Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.